Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.05%
Variazione Mensile
-12.03%
Variazione di 6 mesi
-34.38%
Variazione Annuale
-34.38%
Chiusura Precedente
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
Volume
21
Mercati
Mercato Azionario Statunitense
Salute
BNTC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
25.6 M
26.25 M
33.86 M
34.35 M
—
Valuation ratios
Enterprise value
229.46 M
209.43 M
380.59 M
273.95 M
1.09 B
Price to earnings ratio
-20.33
-11.14
-12.09
-12.36
-55.92
Price to sales ratio
—
507.36
-1 553.57
-1 491.56
—
Price to cash flow ratio
-7.79
-17.96
-19.05
-28.68
-73.48
Price to book ratio
0.55
4.35
1.29
1.17
7.36
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.09
0.06
0.33
Return on equity %
0.1
0.09
0.1
0.06
0.35
Return on invested capital %
—
—
—
—
—
Gross margin %
—
100
—
—
—
Operating margin %
—
-4 581.35
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
-2 692.66
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
14.8
54.67
46.95
67.69
184.12
Inventory turnover
—
—
—
—
—
Asset turnover
0
-0
0
0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.08
0.23
0.08
0.08
0.47
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
2.68
2.7
2.28
4.11
11.77
Net current asset value per share
2.69
2.72
2.29
4.12
11.83
Tangible book value per share
2.53
2.69
2.25
4.08
11.54
Working capital per share
2.51
2.67
2.24
4.06
11.49
Book value per share
2.53
2.69
2.25
4.08
11.54
Notizie
Rating confermato per Benitec BioPharma sui dati di terapia genica
Benitec BioPharma stock rating maintained on gene therapy data
Benitec presenterà i risultati dello studio sulla terapia genica BB-301 a marzo
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Citizens conferma il rating Market Outperform sul titolo Benitec BioPharma
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma mantiene rating Buy da TD Cowen su solidi dati OPMD
Benitec BioPharma stock maintains Buy rating at TD Cowen on strong OPMD data
Baird conferma rating Outperform per Benitec BioPharma con target di $30
Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target
La terapia genica di Benitec mostra risultati duraturi nei pazienti con OPMD